Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProLIS
NCT07613528Phase 3Not yet recruiting
- Sponsor
- CHU Montpellier
- Start
- Mar 2027
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 3 trial of Crinone in luteal phase deficiency (LPD), sponsored by CHU Montpellier. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
Crinone
03
Conditions
luteal phase deficiency (LPD)
Beyond the preview
Go deeper on NCT07613528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07613528.